Linnea M. Baudhuin

Dr. Linnea M. Baudhuin

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2015 in The Journal of Molecular Diagnostics
Verified
Journal Article
Closed access
LBLinnea M. Baudhuin
Linnea M. Baudhuin
SLSusan A. Lagerstedt
Susan A. Lagerstedt
EKEric W. Klee
Eric W. Klee
NFNumrah Fadra
Numrah Fadra
DODevin Oglesbee
Devin Oglesbee
MFMatthew J. Ferber
Matthew J. Ferber

1 August 2010 in The American Journal of Cardiology
Verified
Journal Article
Closed access
LBLinnea M. Baudhuin
Linnea M. Baudhuin
WMWayne L. Miller
Wayne L. Miller
LTLaura Train
Laura Train
SBSandra Bryant
Sandra Bryant
KHKaren A. Hartman
Karen A. Hartman
AJAllan S. Jaffe
Allan S. Jaffe

10 April 2023 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
BIBrenden S. Ingraham
Brenden S. Ingraham
MFMichael E. Farkouh
Michael E. Farkouh
RLRyan J. Lennon
Ryan J. Lennon
DSDerek So
Derek So
SGShaun G. Goodman
Shaun G. Goodman
NPNaveen L. Pereira
Naveen L. Pereira

1 June 2007 in Clinical Biochemistry
Verified
Journal Article
Closed access
LBLinnea M. Baudhuin
Linnea M. Baudhuin
WHW. Edward Highsmith
W. Edward Highsmith
JSJennifer Skierka
Jennifer Skierka
LHLeonard Holtegaard
Leonard Holtegaard
BMBrenda E. Moore
Brenda E. Moore
DODennis J. O'KAne
Dennis J. O'KAne

21 June 2019 in European Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
LBLinnea M. Baudhuin
Linnea M. Baudhuin
MKMichelle L. Kluge
Michelle L. Kluge
KKKatrina E. Kotzer
Katrina E. Kotzer
SLSusan A. Lagerstedt
Susan A. Lagerstedt

1 June 2012 in Clinical Chemistry
Verified
Journal Article
Closed access
PDF file
LBLinnea M. Baudhuin
Linnea M. Baudhuin
Next-generation sequencing (NGS) technology has been moving at an arguably unprecedented pace compared with any other molecular genetics technology to have previously hit the scene. In both the clinical and research settings, this technology demonstrates great appeal because of its tremendous potential to affect medicine via its capacity to more thoroughly interrogate the genome at a fraction of the cost of previous technologies. Two recent articles in the journal Nature highlight the new and changing face of clinical testing and human genetics research. The first, a News in Focus article, discusses the fast-moving pace of NGS technology and some of the benefits and challenges to providing this testing clinically (1). In the second, a commentary article, the author points out the many possibilities for error in human genetics research, and proposes that these testing processes be moved into clinical laboratories (2). A tie-in between these 2 articles is the broad application of NGS to benefit both research participants and clinical patients. Most current …